Stay updated on Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.6.6 appears in the page footer, replacing the old Revision: v3.6.5. This update marks a new build/version of the page rather than a change to study content.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA newer revision label appears, updating from 'Revision: v3.6.4' to 'Revision: v3.6.5'. This reflects an updated build of the page.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page’s revision has been updated from v3.6.3 to v3.6.4, signaling a maintenance release to the ClinicalTrials.gov entry rather than a modification to trial content.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page revision tag changed from v3.6.2 to v3.6.3, signaling a minor update to the ClinicalTrials.gov study page. This update does not modify the study content, eligibility criteria, outcomes, or other substantive details.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the prior v3.6.0, reflecting the latest revision of the study record.SummaryDifference0.0%

- Check81 days agoChange DetectedRecruitment status now shows that no participants are being sought, signaling that enrollment has closed. Other changes are mainly navigational or formatting updates, including the addition of How to Read a Study Record, Common Questions, How to Join a Study, and Revision: v3.6.0, along with the removal of the older Intervention / Treatment heading and Revision: v3.5.5.SummaryDifference0.4%

Stay in the know with updates to Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Thykamine Safety & Efficacy in Atopic Dermatitis Clinical Trial page.